Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-23 · accession 0001628280-26-010602 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-23 | 2026-02-23 | TLSI | Stansky Michael P | Dir | P - Purchase | $4.10 | +243.9K | 787.1K | +45% | +$1000.0K | |
| I | 2026-02-23 | 2026-02-23 | TLSI | Stansky Michael P | Dir | P - Purchase | $4.10 | +117.2K | 199.7K | +142% | +$480.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-23 | P | A | 243,900 | $4.10 | 787,132 | D By LLC | — | — | (F1) These securities were purchased by Skyview Investments LLC. Mr. Stansky serves as managing member of Skyview Investments LLC (and in such capacity may be deemed to beneficially own the securities reported herein). Voting and dispositive power over the securities owned by Skyview Investments LLC is exercised in his capacity as managing member. |
| 2 | Common | Common Stock | 2026-02-23 | P | A | 117,198 | $4.10 | 199,698 | I | — | — |